A high-quality, profitable business with growing sales. Institutions are adding.
Facts from SEC filings, not a recommendation.
From PJT's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
Last 12 months: $1.9B, up 23% from the 12 months before. Over 5 years, sales grew about 10% a year.
Move the sliders to your own view of PJT. Starting points are the company's recent numbers.
What today's price needs: with a 11% margin and a 20x P/E, sales could shrink about 3.1% a year for 5 years and still match today's price.
Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.
Price chart by TradingView.
From annual reports filed with the SEC. Gross margin doesn't apply to banks and insurers, so it isn't scored. Not in this company's SEC data, so not scored: share count not growing. A checklist is a starting point for research, not a verdict.
No open-market insider buys or sells in the last 90 days.
No trades to chart yet.
SEC filings of any kind. 50 means a normal week.
Institutions added 10.1% to their holdings. 212 bought, 151 sold. 2 quarters of net buying in a row.
No offerings, red flags or new big holders. Clean record.
No open-market buys or sells in 90 days. Grants and option exercises are left out.
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
9 shares
15 shares
9 shares
9 shares
5 shares
32 shares
Source: SEC EDGAR filings. For informational purposes. Not investment advice.
Report a problem with this page